Price | 1W % | 1M % | 3M % | 6M % | 1Y % | YTD % |
|---|---|---|---|---|---|---|
-- | -- | -- | -- | -- | -- | -- |
AI Generated Qualitative Analysis
Your time is precious, so save it. Use AI to get the most important information from the business.
Learn about The Cooper Companies, Inc.
The Cooper Companies, Inc. News
The Cooper Companies, Inc. Quantitative Score
About The Cooper Companies, Inc.
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
The Cooper Companies, Inc. Earnings & Revenue
The Cooper Companies, Inc. Financials
Table Compare
Compare COO metrics with: | |||
|---|---|---|---|
Earnings & Growth | COO | None | |
EPS (TTM) YoY Growth | -- | -- | |
Revenue (TTM) YoY Growth | -- | -- | |
Valuation (TTM) | COO | None | |
Price/Earnings Ratio | -- | -- | |
Price/Sales Ratio | -- | -- | |
Profitability & Efficiency (TTM) | COO | None | |
Net Profit Margin | -- | -- | |
Return on Equity | -- | -- | |
Financial Health (TTM) | COO | None | |
Debt/Assets Ratio | -- | -- | |
Assets/Liabilities Ratio | -- | -- | |
The Cooper Companies, Inc. Income
The Cooper Companies, Inc. Balance Sheet
The Cooper Companies, Inc. Cash Flow
The Cooper Companies, Inc. Financials Over Time
Analysts Rating
Strong Buy
Buy
Hold
Sell
Strong Sell
Metrics Scores
| Metrics | Score |
|---|---|
| Discounted Cash Flows | Buy |
| Return on Equity | Neutral |
| Return on Assets | Buy |
| Debt/Equity Ratio | Sell |
| Price/Earnings Ratio | Strong Sell |
| Price/Book Ratio | Neutral |
Price Targets
Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.
The Cooper Companies, Inc. Dividends
| Yield (TTM) | Dividend (TTM) | |
|---|---|---|
Infinity% | 0.1200 |
| Payment Date | Dividend | Frequency |
|---|---|---|
| 2023-08-11 | 0.03 | Quarterly |
| 2023-02-10 | 0.03 | Quarterly |
| 2022-08-11 | 0.03 | Quarterly |
| 2022-02-09 | 0.03 | Quarterly |
| 2021-08-11 | 0.03 | Quarterly |
Historical Market Cap
Shares Outstanding
The Cooper Companies, Inc. Executives
| Name | Role |
|---|---|
| Mr. Albert G. White III | President, Chief Executive Officer & Non-Independent Director |
| Mr. Daniel G. McBride Esq. | Executive Vice President & Chief Operating Officer |
| Mr. Brian G. Andrews | Executive Vice President, Chief Financial Officer & Treasurer |
| Ms. Holly R. Sheffield | President of CooperSurgical, Inc. |
| Mr. Gerard H. Warner III | President of CooperVision, Inc. |
| Name | Role | Gender | Date of Birth | Pay |
|---|---|---|---|---|
| Mr. Albert G. White III | President, Chief Executive Officer & Non-Independent Director | Male | 1970 | 2.91M |
| Mr. Daniel G. McBride Esq. | Executive Vice President & Chief Operating Officer | Male | 1964 | 1.6M |
| Mr. Brian G. Andrews | Executive Vice President, Chief Financial Officer & Treasurer | Male | 1979 | 1.22M |
| Ms. Holly R. Sheffield | President of CooperSurgical, Inc. | Female | 1971 | 1.1M |
| Mr. Gerard H. Warner III | President of CooperVision, Inc. | Male | 1965 | 1M |
The Cooper Companies, Inc. Insider Trades
| Date | 1 Apr |
| Name | WEISS ROBERT S |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 3180 |
| Date | 1 Apr |
| Name | WEISS ROBERT S |
| Role | Director |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 3180 |
| Date | 1 Apr |
| Name | WEISS ROBERT S |
| Role | Director |
| Transaction | Acquired |
| Type | A-Award |
| Shares | 2993 |
| Date | 1 Apr |
| Name | Rivas Maria |
| Role | Director |
| Transaction | Acquired |
| Type | M-Exempt |
| Shares | 2892 |
| Date | 1 Apr |
| Name | Rivas Maria |
| Role | Director |
| Transaction | Disposed |
| Type | M-Exempt |
| Shares | 2892 |
| Date | Name | Role | Transaction | Type | Shares |
|---|---|---|---|---|---|
| 1 Apr | WEISS ROBERT S | Director | Acquired | M-Exempt | 3180 |
| 1 Apr | WEISS ROBERT S | Director | Disposed | M-Exempt | 3180 |
| 1 Apr | WEISS ROBERT S | Director | Acquired | A-Award | 2993 |
| 1 Apr | Rivas Maria | Director | Acquired | M-Exempt | 2892 |
| 1 Apr | Rivas Maria | Director | Disposed | M-Exempt | 2892 |